SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Biogen Drug Benefits Increase at Two Years

Biogen's anti-tau Alzheimer's drug slowed cognitive decline by 38% at two years.

BIIB

Related stories